Researchers from the Stanford University School of Medicine have reported that fenoldopam mesylate, a selective dopamine 1 receptor agonist which is used intravenously for the treatment of hypertension in adults, can also be effective in producing deliberate hypotension in children scheduled to undergo a surgery. The study, according to the lead author, Dr. Gregory Hammer, affects pediatric labeling for fenoldopam and guides practitioners about appropriate intraoperative dosing for deliberate hypotension.